SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001104659-23-062755 from AGILE THERAPEUTICS INC (AGRX, AGXRW) (CIK 0001261249)

AGILE THERAPEUTICS INC (AGRX, AGXRW) (CIK 0001261249)
Date: May 19, 2023 · CIK: 0001261249 · Accession: 0001104659-23-062755

AI Filing Summary & Sentiment

File numbers found in text: 333-271249

Date
May 19, 2023
Author
H.C. WAINWRIGHT & CO., LLC
Form
CORRESP
Company
AGILE THERAPEUTICS INC (AGRX, AGXRW) (CIK 0001261249)

Letter

Re: Agile Therapeutics, Inc.

May 19, 2023

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Washington, D.C. 20549

Registration Statement on Form S-1 (File No. 333-271249)

Concurrence in Acceleration Request

Ladies and Gentlemen:

H.C. Wainwright & Co., LLC (“Wainwright”), as placement agent for the referenced offering, hereby concurs in the request by Agile Therapeutics, Inc. that the effective date of the above-referenced registration statement be accelerated to Monday, May 22, 2023, at 3:00 p.m. (Washington, D.C. time), or as soon as practicable thereafter, pursuant to Rule 461 under the Securities Act. Wainwright affirms that it is aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement.

Very truly yours,
H.C. WAINWRIGHT & CO., LLC

Show Raw Text
CORRESP
1
filename1.htm

May 19, 2023

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Washington, D.C. 20549

    Re:
    Agile Therapeutics, Inc.

    Registration Statement on Form S-1 (File No. 333-271249)

    Concurrence in Acceleration Request

Ladies and Gentlemen:

H.C. Wainwright &
Co., LLC (“Wainwright”), as placement agent for the referenced offering, hereby concurs in the request by Agile Therapeutics,
Inc. that the effective date of the above-referenced registration statement be accelerated to Monday, May 22, 2023, at 3:00
p.m. (Washington, D.C. time), or as soon as practicable thereafter, pursuant to Rule 461 under the Securities Act. Wainwright affirms
that it is aware of its obligations under the Securities Act  as they pertain to the best efforts offering pursuant to the Registration Statement.

    Very truly yours,

    H.C. WAINWRIGHT & CO., LLC

    By:
    /s/ Edward D. Silvera

    Name: Edward D. Silvera

    Title: Chief Operating Officer